| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.15 | 0.006 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.007 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.091 | 0.007 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.16 | 0.007 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.007 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.007 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.007 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | 0.078 | 0.008 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.008 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | 0.15 | 0.008 |